Evidence map›Paper›PMID 18385739›Full record

ArticleNature2008

A variant associated with nicotine dependence, lung cancer and peripheral arterial disease.

Thorgeir E Thorgeirsson, Frank Geller, Patrick Sulem, Thorunn Rafnar, Anna Wiste, Kristinn P Magnusson, Andrei Manolescu, Gudmar Thorleifsson, Hreinn Stefansson, Andres Ingason and 47 more

Registry-linked trialAbstract read
In one paragraph

Article in Nature, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01780038 (Smokers' Response to Nicotine Dependence Genotyping), which is not on this map. Cited by 856 papers, 13 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
856citing papers in PubMed, 13 pooled it
73.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01780038 nacompletednot on this mapstarted 2012, after this paper: background citation

Smokers' Response to Nicotine Dependence Genotyping

TypeinterventionalSponsorUniversity of NebraskaRan2012 to 2013Enrolled24ConditionsCigarette Smoking, Nicotine DependenceArmsReceipt of Genetic Results, No results given
3 · Its place in the literature

Who cites it

856 citing papers in PubMed, 13 syntheses or guidelines pooled it, 1,519 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. The Shared Genetic Architectures Between Lung Cancer and Multiple Polygenic Phenotypes in Genome-Wide Association Studies.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2021
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.Journal of the National Comprehensive Cancer Network : JNCCN · 2018
    Guideline
  13. Pooled it
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Review
  19. Article
  20. Observational

796 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

57 authors at 12 institutions in 6 countries.

Thorgeir E Thorgeirsson *deCODE Genetics, Reykjavik Iceland.
Frank Geller *deCODE Genetics, Reykjavik Iceland.
Patrick Sulem *deCODE Genetics, Reykjavik Iceland.
Thorunn Rafnar *deCODE Genetics, Reykjavik Iceland.
Anna WistedeCODE Genetics, Reykjavik Iceland.
Kristinn P MagnussondeCODE Genetics, Reykjavik Iceland.
Andrei ManolescudeCODE Genetics, Reykjavik Iceland.
Gudmar ThorleifssondeCODE Genetics, Reykjavik Iceland.
Hreinn StefanssondeCODE Genetics, Reykjavik Iceland.
Andres IngasondeCODE Genetics, Reykjavik Iceland.
Simon N StaceydeCODE Genetics, Reykjavik Iceland.
Jon T BergthorssondeCODE Genetics, Reykjavik Iceland.
Steinunn ThorlaciusdeCODE Genetics, Reykjavik Iceland.
Julius GudmundssondeCODE Genetics, Reykjavik Iceland.
Thorlakur JonssondeCODE Genetics, Reykjavik Iceland.
Margret JakobsdottirdeCODE Genetics, Reykjavik Iceland.
Jona SaemundsdottirdeCODE Genetics, Reykjavik Iceland.
Olof OlafsdottirdeCODE Genetics, Reykjavik Iceland.
Larus J GudmundssondeCODE Genetics, Reykjavik Iceland.
Gyda BjornsdottirdeCODE Genetics, Reykjavik Iceland.
Kristleifur KristjanssondeCODE Genetics, Reykjavik Iceland.
Halla SkuladottirLandspitali University Hospital, Department of Medical Oncology, Reykjavik Iceland.
Helgi J IsakssonLandspitali University Hospital, Department of Pathology, Reykjavik Iceland.
Tomas GudbjartssonLandspitali University Hospital, Department of Cardiothoracic Surgery, Reykjavik Iceland.
Gregory T JonesDepartment of Surgery, Dunedin School of Medicine, University of Otago, New Zealand.
Thomas MuellerDepartment of Laboratory Medicine, Konventhospital Barmherzige Brueder, Linz, Austria.
Anders GottsäterCenter for Vascular Diseases, University Hospital. MAS, Malmö, Sweden.
Andrea FlexLaboratory of Vascular Biology & Genetics, A. Gemelli University Hospital,Universita Cattolica del Sacro Cuore School of Medicine, Rome, Italy.
Katja K H AbenRadboud University Nijmegen Medical Centre, Department of Epidemiology & Biostatistics, Nijmegen, Netherlands.
Femmie de VegtRadboud University Nijmegen Medical Centre, Department of Epidemiology & Biostatistics, Nijmegen, Netherlands.
Peter F A MuldersRadboud University Nijmegen Medical Centre, Department of Urology, Nijmegen, Netherlands.
Dolores IslaUniversity Hospital, Division of Medical Oncology, Zaragoza Spain.
Maria J VidalUniversity Hospital, Division of Medical Oncology, Zaragoza Spain.
Laura AsinNanotechnology Institute of Aragon, Zaragoza Spain.
Berta SaezHealth Science Institute, Zaragoza Spain.
Laura MurilloHospital Reina Sofia, Division of Medical Oncology, Tudela Spain.
Thorsteinn BlondalReykjavik Primary Health Care Centre, Department of Lung Disease, Reykjavik Iceland.
Halldor KolbeinssonLandspitali University Hospital, Department of General Adult Psychiatry, Reykjavik Iceland.
Jon G StefanssonLandspitali University Hospital, Department of General Adult Psychiatry, Reykjavik Iceland.
Ingunn HansdottirVogur SAA Addiction Treatment Center, Reykjavik Iceland.
Valgerdur RunarsdottirVogur SAA Addiction Treatment Center, Reykjavik Iceland.
Roberto PolaLaboratory of Vascular Biology & Genetics, A. Gemelli University Hospital,Universita Cattolica del Sacro Cuore School of Medicine, Rome, Italy.
Bengt LindbladCenter for Vascular Diseases, University Hospital. MAS, Malmö, Sweden.
Andre M van RijDepartment of Surgery, Dunedin School of Medicine, University of Otago, New Zealand.
Benjamin DieplingerDepartment of Laboratory Medicine, Konventhospital Barmherzige Brueder, Linz, Austria.
Meinhard HaltmayerDepartment of Laboratory Medicine, Konventhospital Barmherzige Brueder, Linz, Austria.
Jose I MayordomoUniversity Hospital, Division of Medical Oncology, Zaragoza Spain.
Lambertus A KiemeneyRadboud University Nijmegen Medical Centre, Department of Epidemiology & Biostatistics, Nijmegen, Netherlands.
Stefan E MatthiassonUniversity of Iceland, School of Medicine, Reykjavik Iceland.
Hogni OskarssonTherapeia, Reykjavik Iceland.
Thorarinn TyrfingssonVogur SAA Addiction Treatment Center, Reykjavik Iceland.
Daniel F GudbjartssondeCODE Genetics, Reykjavik Iceland.
Jeffrey R GulcherdeCODE Genetics, Reykjavik Iceland.
Steinn JonssonLandspitali University Hospital, Department of Medicine, Reykjavik Iceland.
Unnur ThorsteinsdottirdeCODE Genetics, Reykjavik Iceland.
Augustine KongdeCODE Genetics, Reykjavik Iceland.
Kari StefanssondeCODE Genetics, Reykjavik Iceland.
deCODE Genetics (Iceland) · ISConvent Hospital of the Brothers of Saint John of God · ATRadboud University Medical Center · NLSociety of Alcoholism and other Addictions · ISUniversidad de Zaragoza · ESUniversity of Iceland · ISUniversità Cattolica del Sacro Cuore · ITUniversity of Otago · NZHospital Universitario Reina Sofía · ESInstituto de Nanociencia y Materiales de Aragón · ESNational University Hospital of Iceland · ISRadboud University Nijmegen · NL

Funding

Genes contributing to nicotine dependence in humansR01DA017932 · NIDA · DECODE GENETICS, INC. · PI STEFANSSON, KARI · 2005 to 2015
$9.6M
NIDA NIH HHS R01 DA017932
6 · The paper itself

Abstract

Smoking is a leading cause of preventable death, causing about 5 million premature deaths worldwide each year. Evidence for genetic influence on smoking behaviour and nicotine dependence (ND) has prompted a search for susceptibility genes. Furthermore, assessing the impact of sequence variants on smoking-related diseases is important to public health. Smoking is the major risk factor for lung cancer (LC) and is one of the main risk factors for peripheral arterial disease (PAD). Here we identify a common variant in the nicotinic acetylcholine receptor gene cluster on chromosome 15q24 with an effect on smoking quantity, ND and the risk of two smoking-related diseases in populations of European descent. The variant has an effect on the number of cigarettes smoked per day in our sample of smokers. The same variant was associated with ND in a previous genome-wide association study that used low-quantity smokers as controls, and with a similar approach we observe a highly significant association with ND. A comparison of cases of LC and PAD with population controls each showed that the variant confers risk of LC and PAD. The findings provide a case study of a gene-environment interaction, highlighting the role of nicotine addiction in the pathology of other serious diseases.

Indexed as

Chromosomes, Human, Pair 15EuropeFemaleGenetic Predisposition to DiseaseGenotypeHumansLung NeoplasmsMaleMultigene FamilyNew ZealandOdds RatioPeripheral Vascular DiseasesPolymorphism, Single NucleotideReceptors, NicotinicSmokingTobacco Use DisorderReceptors, Nicotinic

Identifiers

PMID18385739
PMCPMC4539558
OpenAlexW2118082971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.